In this manuscript, the authors describe their findings after reviewing 27 young patients (between 7 and 30 years of age) who had undergone aortic valve replacement with two types of bovine pericardial biological prosthesis: Mitroflow® LXA (15 patients) and PERIMOUNT Magna® and Magna Ease® (12 patients) valves.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease (congenital)
May 4, 2014
April 1, 2014
This video shows a teenager with a large neo-aortic root aneurysm and severe aortic valve regurgitation following a Ross procedure, which was treated with a valve-sparing aortic root replacement. The case also highlights the intra-operative management of inadvertent aortic injury during reentry in the setting of severe aortic regurgitation.
September 5, 2012
The authors demonstrate the steps for three-patch repair of congenital supravalvar aortic stenosis in a 5 month old.
July 11, 2012
The Ross procedure is a valuable alternative for the surgical treatment of aortic valve disease in adolescent and young adult. However, neo-aortic root dilatation resulting in valve regurgitation is not uncommon. This video demonstrates the authors' technical modification that prevents this complication.
July 11, 2012
The lack of an ideal valve substitute in the congenitally affected aortic valve has raised the interest in aortic valvuloplasty by leaflet extensions. Several techniques using native or xenopericardium have been described for aortic valve repair, however, the ideal material for leaflet extensions still remains controversial.
